Open, Prospective, Multi-Center, Two-Part Study of Patient Preference with Monthly Ibandronate Therapy in Women with Postmenopausal Osteoporosis Switched From Daily or Weekly Alendronate or Risendronate-BONCURE: Results of Turkish Sub-Study

Open, Prospective, Multi-Center, Two-Part Study of Patient Preference with Monthly Ibandronate Therapy in Women with Postmenopausal Osteoporosis Switched From Daily or Weekly Alendronate or Risendronate-BONCURE: Results of Turkish Sub-Study

Aim: BONCURE (Bonviva for Current Bisphosphonate Users Regional European Trial), aimed to evaluate patient preference with monthly ibandronate in women with postmenopausal osteoporosis who previously received daily or weekly alendronate or risendronate. Materials and Methods: This prospective, ope...

Full description

Bibliographic Details
Main Authors: Nurten Eskiyurt, Jale İrdesel, Vesile Sepici
Format: Article
Language:English
Published: Galenos Yayinevi 2012-04-01
Series:Türk Osteoporoz Dergisi
Subjects:
Bisphosphonate
ibandronate
postmenopausal osteoporosis
patient preference
Online Access:http://www.turkosteoporozdergisi.org/article_4291/Open-Prospective-Multi-center-Two-part-Study-Of-Patient-Preference-With-Monthly-Ibandronate-Therapy-In-Women-With-Postmenopausal-Osteoporosis-Switched-From-Daily-Or-Weekly-Alendronate-Or-Risendronate-boncure-Results-Of-Turkish-Sub-study

Internet

http://www.turkosteoporozdergisi.org/article_4291/Open-Prospective-Multi-center-Two-part-Study-Of-Patient-Preference-With-Monthly-Ibandronate-Therapy-In-Women-With-Postmenopausal-Osteoporosis-Switched-From-Daily-Or-Weekly-Alendronate-Or-Risendronate-boncure-Results-Of-Turkish-Sub-study

Similar Items